Sanzyme is a Biopharmaceutical company, Generics/Biosimilars Manufacturer company operating in the pharmaceutical industry.
SANZYME, earlier known as UNI SANKYO, is the first ever Indo-Japanese pharmaceutical joint venture in INDIA. Established in 1969, Sanzyme is the 1st generation biotechnology company expertise in manufacturing of Infertility Hormones(Gonadotropins) and Probiotics. The Gonadotropins facility is approved by EU Drug Regulatory Authority and all set to enter European Market with ready eCTD dossier.
Company type
Biopharmaceutical company, Generics/Biosimilars Manufacturer
Products and services
Pharmaceutical Products / ATC coding, Finished Dosage Forms, Contract Services – Analytical & Lab Services
Markets
Oceania, Africa, Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – non EU (e.g. UK, Russia, ex-CIS countries), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)
Address
Sanzyme, Plot no 13, Sagar Society, Road No 2, Banjara Hills, Hyderabad / Telangana, Telangana, India, 500034
